Compare Lumentum (LITE) vs Medpace Holdings Inc (MEDP) Price & Performance

LumentumTrade

Medpace Holdings IncTrade

Price performance (Past 24H)

Key statistics

Lumentum vs Medpace Holdings Inc — how do they compare? Lumentum trades at $1,115.27 (market cap $94.99B), while Medpace Holdings Inc trades at $616.43 (market cap $16.82B). The key difference: Lumentum is far larger — about 5.6× Medpace Holdings Inc's market cap, and Medpace Holdings Inc is more actively traded (223,093 versus 4,855,776). Which is the better fit depends on your goals — on Pluang, investors hold Lumentum for 4 Days and Medpace Holdings Inc for 14 Days on average.

	LITE	MEDP
Market Cap	$94.99B	$16.82B
Volume	4,855,776	223,093
Sector	Technology	Health
52-Week High	$1.13K	$630.19
52-Week Low	$149.61	$393.42
Typical Hold Time	4 Days	14 Days
Enterprise Value	$93.92B	$16.44B

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Lumentum

No Aura AI signal available yet.

Medpace Holdings Inc

Medpace (MEDP) trades at $617.47, up 2.19% with strong quarterly earnings beats and robust profitability metrics. The stock shows neutral technical signals with key resistance at $620, while fundamentals reveal impressive ROE of 162.15% and consistent revenue growth to $2.8B projected for 2026. Recent CEO stock sales and mixed institutional activity create balanced sentiment ahead of Q3 earnings announcement on October 21, 2026.

MEDP presents growth potential with analyst consensus target of $620.44 and strong historical execution, though elevated valuations (P/E 35.41) and insider selling warrant caution. The stock's upside depends on continued earnings delivery amid competitive medical services landscape.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

LITE

54% Buy46% Sell

Avg holding period · 4 Days

MEDP

100% Buy0% Sell

Avg holding period · 14 Days

Top news

Latest headlines on both assets

LITE

Lumentum hits strong demand amid AI data center growth, may be undervalued with $40 EPS target by 2028Seeking Alpha · 4 hours agoBullish Lumentum warns AI demand fills production capacity through early 2029, shares rise 4%.Proactive Investors · 8 hours agoBullish Optical stocks surge as capacity sold out through 2029, driven by strong AI data center demand.24/7 Wall Street · 10 hours agoBullish View details →

MEDP

View details →

About Lumentum

Lumentum develops photonic products, including optical components, transceivers, and lasers. Its technologies support data centers, communications networks, industrial manufacturing, and sensing applications.

About Medpace Holdings Inc

Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.